🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

That is why research is essential: to discover new drugs! That is why research is the great equalizer: if your methods are solid and your discovery is important, it does not matter whether you are a second-year med student or a full professor

A real honor to give the Opening Lecture at this HFpEF conference! Very comprehensive program and a stellar group of panelists! Soc Esp Cardiología Do not miss it!

Absolutely true! Statistics are basic for science. Randomization always superior to propensity-score matching

Hear, hear!

So honored to be able to offer my perspective about the benefits of SGLT2i in heart failure in this article by the great Michael O'Riordan and TCTMD. An honor and a pleasure to work with you1 #GDMT #flozinator tctmd.com/news/analysis-…

Great pairing with this tweet by the great Gregg Fonarow MD "What does this say about discharging a HFrEF patient without ARNI+BB+MRA+SGLT2i?" x.com/gcfmd/status/1…

Completely agree with this statement (also including history, imaging, ...)

Everything you wanted to know about the CLEAR-Outcomes trial, but were afraid to ask. Read my view on the latest Soc Esp Cardiología blog entry LDL, the lower the better, the earlier the better! secardiologia.es/blog/14179-que… LipidMIR ResiSEC #cardioed #meded Capijorge

Should we consider increased ketone body levels as one of the mechanisms of action involved in the cardiorenal benefit of SGLT2i? Our recent article supports this concept! @santosgallegoMD Juan Antonio Requena-Ibáñez, MD @dlbhattmd Icahn School of Medicine at Mount Sinai Mount Sinai Cardiology Fellowship ahajournals.org/doi/abs/10.116…

I have learnt so many concepts about RV evaluation from thr master himself, the one and only Ryan J Tedford MD, in the Grand Rounds at #McMaster organized by Harriette Van Spall, MD MPH 🇨🇦 Importance of RV/PA coupling over contractility, of exercise/pharmacological reserve over at-rest evaluation,…

Are the benefits of sotatagliflozin observed in T2DM also present in non-diabetic HFpEF? Be patient and wait for the results of the ongoing SOTA-P-CARDIA trial!! Carlos G Santos-Gallego, MD Juan Antonio Requena-Ibáñez, MD Capijorge Maeve Soto Pérez link.springer.com/article/10.100…

Wow! An SGLT2i is sold at $47.85!!!! (shipping included) 🥳🍾🎉🤑💸 That is 8% of the going price of empagliflozin or dapagliflozin!! Caveat: Only indication in T2DM (not HF or CKD) fiercepharma.com/pharma/theraco… Christos Argyropoulos MD PhD FlozinatorInChief🇺🇸 Jonathan Davis, MD, MPHS Andrew J Sauer MD Harriette Van Spall, MD MPH 🇨🇦 Anu Lala-Trindade

What a tour de force by the amazing Pam R. Taub, MD❤️💃🏻 as Visiting Professor at @MountSinaiHear! She masterfully took us through her journey from cardiometabolism to time-restricted eating to POTS to Long Covid, all with impeccable scientific accumen and humility! Dr. Deepak L. Bhatt

Hear hear! Reducing endomyocardial biopsies in heart transplant surveillance will improve quality of life of patients! Plus Jeff Teuteberg as a person is amazing!